- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sintilimab plus chemotherapy
Total 7726 results
-
Ningbo No.2 HospitalNot yet recruitingCarcinoma, Non-Small-Cell Lung
-
Second Affiliated Hospital of Guangzhou Medical...Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Henan Cancer HospitalCompletedExtensive Disease Small Cell Lung CancerChina
-
Shanghai Cancer Hospital, ChinaUnknown
-
Chinese PLA General HospitalUnknownMetastasis Colorectal CancerChina
-
Shandong Cancer Hospital and InstituteUnknownCarcinoma, Non-Small Cell LungChina
-
Tongji HospitalThe Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaboratorsRecruitingHepatocellular Carcinoma Non-resectableChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingMelanoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Pancreas Cancer | Colo-rectal Cancer | Renal Cancer | HepatocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Guohui LiRecruitingPD-1 | Immune Related Adverse EventsChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Lung CancerChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Cancer Institute and Hospital, Chinese Academy...CompletedAdvanced Hepatocellular CarcinomaChina
-
Peking UniversityInnovent Biologics (Suzhou) Co. Ltd.UnknownAdvanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
Hubei Cancer HospitalRecruitingMetastatic Lung Cancer | Elderly PatientsChina
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingAdvanced Biliary Tract CancerChina
-
West China HospitalFirst Affiliated Hospital of Chongqing Medical University; Sichuan Cancer Hospital... and other collaboratorsRecruitingRectal Cancer | Radiotherapy | Anti-PD-1 Antibody | MSI-H | Mmr DeficiencyChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Second Affiliated Hospital of Guangzhou Medical...Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Shenzhen... and other collaboratorsActive, not recruitingHepatocellular Carcinoma Non-resectableChina
-
West China HospitalActive, not recruitingCarcinoma, Renal Cell | Immunotherapy | Fumarate Hydratase DeficiencyChina
-
RenJi HospitalNot yet recruitingThird-line Treatment | Dvanced Duodenal Adenocarcinoma | Furquinelone Combined With Sintilimab
-
Beijing Tsinghua Chang Gung HospitalUnknownHepatocellular Carcinoma | Portal Vein Tumor ThrombosisChina
-
Changzhou Cancer Hospital of Soochow UniversityUnknownSmall Cell Lung CancerChina
-
Xiaorong DongUnknownBrain Metastases | NSCLC Stage IV | Sintilimab | SRSChina
-
Shengjing HospitalRecruitingBreast Cancer | Immunotherapy | Stereotactic RadiotherapyChina
-
Xijing HospitalNot yet recruitingSintilimab | Neoadjuvant Chemotherapy | Locally Advanced Gastric Cancer
-
AstraZenecaCompletedSmall Cell Lung Carcinoma Extensive DiseaseChina
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Kyungpook National University HospitalNational Cancer Center, Korea; Chonnam National University Hospital; Daegu Catholic... and other collaboratorsUnknownAdvanced Gastric Cancer With Serosal InvasionKorea, Republic of
-
Tongji HospitalNot yet recruitingHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalInnovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Peking Union Medical College HospitalHenan Cancer Hospital; Qilu Hospital of Shandong University; Beijing Tongren... and other collaboratorsRecruitingPrimary Central Nervous System LymphomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
AIPING ZHOUUnknown
-
Shanghai Zhongshan HospitalCompleted
-
Sun Yat-sen UniversityActive, not recruitingLocal Advanced High Risk Nasopharyngeal CarcinomaChina
-
Fujian Cancer HospitalNot yet recruiting
-
Tianjin Medical University Cancer Institute and...RecruitingPancreatic Carcinoma | Neuroendocrine Carcinoma | Neuroendocrine Tumor Grade 3China
-
The First Affiliated Hospital of Xiamen UniversityNot yet recruiting
-
Sun Yat-sen UniversityCompletedRadiotherapy | Sintilimab | Anlotinib | Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Early Stage | Peg-aspargase | Phase Two | OpenChina
-
Shanghai Zhongshan HospitalRecruitingEsophageal Squamous Cell Carcinoma | Neoadjuvant ChemoimmunotherapyChina
-
Zhao ChongCancer Institute and Hospital, Chinese Academy of Medical Sciences; Jiangxi... and other collaboratorsCompletedLocal Advanced High Risk Nasopharyngeal CarcinomaChina
-
Wan-Guang ZhangThe Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaboratorsRecruitingHepatocellular Carcinoma Non-resectableChina
-
Samsung Medical CenterUnknownNon-small Cell Lung Cancer MetastaticKorea, Republic of
-
Biotech Pharmaceutical Co., Ltd.Not yet recruitingGastric or Esophagogastric Junction Adenocarcinoma
-
Blokhin's Russian Cancer Research CenterRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingRadiotherapy | Rectal Neoplasms MalignantChina
-
Zhejiang Cancer HospitalNot yet recruiting